A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
Public ClinicalTrials.gov record NCT06212999. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate long-term safety and efficacy of povorcitinib in participants with moderate to severe hidradenitis suppurativa who completed the 54 weeks of study treatment within the originating parent Phase 3 studies (INCB 54707-301 \[NCT05620823\] or INCB 54707-302 \[NCT05620836\]).
Study identification
- NCT ID
- NCT06212999
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 617 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 30, 2024 (Actual)
- Primary completion
- Dec 26, 2026 (Estimated)
- Completion
- Dec 26, 2026 (Estimated)
- Last update posted
- Aug 25, 2026
2024 – 2026
United States locations
- U.S. sites
- 61
- U.S. states
- 24
- U.S. cities
- 54
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative Site US303 | Phoenix | Arizona | 85006 | — |
| Investigative Site US240 | Scottsdale | Arizona | 85255 | — |
| Investigative Site US307 | Fort Smith | Arkansas | 72916 | — |
| Investigative Site US214 | Rogers | Arkansas | 72758 | — |
| Investigative Site US315 | Laguna Niguel | California | 92677 | — |
| Investigative Site US223 | Los Angeles | California | 90033 | — |
| Investigative Site US222 | Oakland | California | 94611 | — |
| Investigative Site US226 | San Diego | California | 92103 | — |
| Investigative Site US309 | Clearwater | Florida | 33614 | — |
| Investigative Site US317 | Hialeah | Florida | 33012-3618 | — |
| Investigative Site US306 | Hollywood | Florida | 33021 | — |
| Investigative Site US320 | Hollywood | Florida | 33021 | — |
| Investigative Site US316 | Maitland | Florida | 32751 | — |
| Investigative Site US227 | Margate | Florida | 33063 | — |
| Investigative Site US204 | Miami | Florida | 33125 | — |
| Investigative Site US236 | Miami | Florida | 33173 | — |
| Investigative Site US321 | North Miami Beach | Florida | 33162-4708 | — |
| Investigative Site US200 | Ocala | Florida | 34470 | — |
| Investigative Site US228 | Tampa | Florida | 33609 | — |
| Investigative Site US201 | Tampa | Florida | 33613 | — |
| Investigative Site US311 | Marietta | Georgia | 30060 | — |
| Investigative Site US220 | West Dundee | Illinois | 60118 | — |
| Investigative Site US206 | Indianapolis | Indiana | 46250 | — |
| Investigative Site US337 | Indianapolis | Indiana | 46250 | — |
| Investigative Site US341 | Bowling Green | Kentucky | 42104 | — |
| Investigative Site US209 | Louisville | Kentucky | 40241 | — |
| Investigative Site US305 | Baton Rouge | Louisiana | 70809 | — |
| Investigative Site US207 | Metairie | Louisiana | 70006 | — |
| Investigative Site US229 | New Orleans | Louisiana | 70115 | — |
| Investigative Site US224 | Baltimore | Maryland | 21287 | — |
| Investigative Site US325 | Marriottsville | Maryland | 21104 | — |
| Investigative Site US225 | Boston | Massachusetts | 02115 | — |
| Investigative Site US304 | Boston | Massachusetts | 02215 | — |
| Investigative Site US310 | Brighton | Massachusetts | 02135 | — |
| Investigative Site US221 | Quincy | Massachusetts | 02169 | — |
| Investigative Site US213 | Fort Gratiot | Michigan | 48059 | — |
| Investigative Site US217 | Waterford | Michigan | 48328 | — |
| Investigative Site US212 | Minneapolis | Minnesota | 55455 | — |
| Investigative Site US302 | St Louis | Missouri | 63110 | — |
| Investigative Site US318 | Portsmouth | New Hampshire | 03801 | — |
| Investigative Site US230 | East Windsor | New Jersey | 08520 | — |
| Investigative Site US324 | Kew Gardens | New York | 11415 | — |
| Investigative Site US202 | New York | New York | 10028 | — |
| Investigative Site US210 | Rochester | New York | 14620 | — |
| Investigative Site US205 | Chapel Hill | North Carolina | 27516 | — |
| Investigative Site US215 | Bexley | Ohio | 43209 | — |
| Investigative Site US339 | Bexley | Ohio | 43209 | — |
| Investigative Site US330 | Boardman | Ohio | 44512 | — |
| Investigative Site US314 | Cincinnati | Ohio | 45219 | — |
| Investigative Site US312 | Cleveland | Ohio | 44106 | — |
| Investigative Site US203 | Gahanna | Ohio | 43230 | — |
| Investigative Site US301 | Portland | Oregon | 97201 | — |
| Investigative Site US232 | Murfreesboro | Tennessee | 37130 | — |
| Investigative Site US235 | Arlington | Texas | 76011 | — |
| Investigative Site US218 | Bellaire | Texas | 77401 | — |
| Investigative Site US340 | Bellaire | Texas | 77401 | — |
| Investigative Site US238 | Pflugerville | Texas | 78660 | — |
| Investigative Site US300 | Plano | Texas | 75025 | — |
| Investigative Site US234 | San Antonio | Texas | 78213 | — |
| Investigative Site US313 | Norfolk | Virginia | 23502 | — |
| Investigative Site US308 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 104 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06212999, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2026 · Synced Oct 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06212999 live on ClinicalTrials.gov.